Beyond Air Inc (FRA:48L)
€ 65.6 (0%) Market Cap: 5.51 Mil Enterprise Value: 15.77 Mil PE Ratio: 0 PB Ratio: 0.69 GF Score: 25/100

Q1 2027 Beyond Air Inc Earnings Call Transcript

Aug 13, 2026 / 12:00PM GMT
Release Date Price: €65.6

Key Points

Positve
  • Beyond Air Inc (XAIR) strengthened its balance sheet with an up to $30 million financing, providing $10 million in upfront proceeds and potential for additional $20 million from warrants.
  • The company regained compliance with Nasdaq's listing requirements, reducing regulatory and listing risks.
  • Beyond Air Inc (XAIR) secured a third national group purchasing agreement with a leading US GPO, expanding market access to a substantial portion of US hospitals alongside Premier and Vizient.
  • The company's global distribution network now covers more than 40 countries, with plans to support international partners' market entry.
  • Gross margin improved to 13% from 9% year-over-year, marking the third consecutive quarter of positive gross profit.
  • The commercial pipeline doubled over the last five to six months, indicating growing demand and potential for future revenue growth.
  • Beyond Air Inc (XAIR) reaffirmed its 2026 revenue guidance of $8 million and 2027 guidance of $16-18 million, reflecting confidence in growth trajectory.
  • The FDA review process for the Gen II LungFit PH system is progressing well, with positive communication and timely paperwork submissions, keeping approval on track for H2 2026.
Negative
  • Revenue for the quarter ended June 30, 2026, was flat at $1.8 million, showing no growth compared to the prior quarter.
  • The company reported a net loss of $7.9 million for the quarter, with losses per share improving only due to a higher share count.
  • Cash position remains tight at $15.2 million as of June 30, 2026, excluding the recent financing, indicating ongoing cash burn.
  • The FDA approval for the Gen II LungFit PH system is still pending, with no exact timeline, and potential approval is likely pushed to Q4 2026, creating uncertainty.
  • The company's 2026 revenue guidance excludes any contribution from the Gen II system, highlighting reliance on existing products for near-term growth.
  • Other expenses increased significantly to $1.5 million from $500,000 year-over-year, impacting overall financial performance.
  • The company is in a cash burn position, and the recent financing will be used to absorb operational burn, limiting flexibility for other investments.
  • International expansion is still in early stages, with revenue recognition from these markets not yet materializing significantly.
Operator

Greetings, and welcome to the Beyond Air Financial Results for the quarter ending June 30, 2026. (Operator Instructions)

And now I would like to turn the call over to Corey Davis, LifeSci Advisors. Please go ahead.

Corey Davis
Beyond Air Inc - Investor Relations

Thank you, Operator. Good morning, everyone, and thank you for joining us. Earlier today, we issued a press release announcing the operational highlights and financial results for Beyond Air's quarter ended June 30, 2026. A copy of this press release can be found on our website, beyondair.net, under the News and Events section.

Before we begin, I'd like to remind everyone that we will be making comments and various remarks about future expectations, plans, and prospects, which constitute forward-looking statements for purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. Beyond Air cautions that these forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those indicated.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot